BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19150714)

  • 1. Tweaking the gain on platelet regulation: the tachykinin connection.
    Gibbins JM
    Atherosclerosis; 2009 Sep; 206(1):1-7. PubMed ID: 19150714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinins regulate the function of platelets.
    Graham GJ; Stevens JM; Page NM; Grant AD; Brain SD; Lowry PJ; Gibbins JM
    Blood; 2004 Aug; 104(4):1058-65. PubMed ID: 15130944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachykinins and tachykinin receptors in bone.
    Goto T; Tanaka T
    Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurokinin 1 receptor: a potential new target for anti-platelet therapy?
    Jones S; Gibbins JM
    Curr Opin Pharmacol; 2008 Apr; 8(2):114-9. PubMed ID: 18296119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin receptors and receptor subtypes.
    Patacchini R; Maggi CA
    Arch Int Pharmacodyn Ther; 1995; 329(1):161-84. PubMed ID: 7639617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.
    Jones S; Tucker KL; Sage T; Kaiser WJ; Barrett NE; Lowry PJ; Zimmer A; Hunt SP; Emerson M; Gibbins JM
    Blood; 2008 Jan; 111(2):605-12. PubMed ID: 17895403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New challenges in the study of the mammalian tachykinins.
    Page NM
    Peptides; 2005 Aug; 26(8):1356-68. PubMed ID: 16042976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P2Y12 receptor in platelet activation.
    Kim S; Kunapuli SP
    Platelets; 2011; 22(1):56-60. PubMed ID: 21231822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
    Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus.
    Patak E; Pinto FM; Story ME; Pintado CO; Fleming A; Page NM; Pennefather JN; Candenas ML
    Biol Reprod; 2005 May; 72(5):1125-33. PubMed ID: 15647454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
    Ting HJ; Khasawneh FT
    Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of platelet functions by P2 receptors.
    Gachet C
    Annu Rev Pharmacol Toxicol; 2006; 46():277-300. PubMed ID: 16402906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tachykinins in the immune system.
    Zhang Y; Berger A; Milne CD; Paige CJ
    Curr Drug Targets; 2006 Aug; 7(8):1011-20. PubMed ID: 16918329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs.
    Gachet C
    Pharmacol Ther; 2005 Nov; 108(2):180-92. PubMed ID: 15955565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets.
    Mazepa M; Hoffman M; Monroe D
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1747-52. PubMed ID: 23864724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian tachykinins and uterine smooth muscle: the challenge escalates.
    Pennefather JN; Patak E; Pinto FM; Candenas ML
    Eur J Pharmacol; 2004 Oct; 500(1-3):15-26. PubMed ID: 15464017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.
    Montalescot G
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):371-80. PubMed ID: 20566574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.